Koszycki D - Search Results

1

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H. Bradwejn J, et al. Among authors: koszycki d. Arch Gen Psychiatry. 1994 Jun;51(6):486-93. doi: 10.1001/archpsyc.1994.03950060050005. Arch Gen Psychiatry. 1994. PMID: 8192551 Clinical Trial.

2

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.

Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C. Bradwejn J, et al. Among authors: koszycki d. Biol Psychiatry. 1992 Nov 15;32(10):903-12. doi: 10.1016/0006-3223(92)90179-4. Biol Psychiatry. 1992. PMID: 1467375 Clinical Trial.

3

Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.

Bradwejn J, Koszycki D, Payeur R, Bourin M, Borthwick H. Bradwejn J, et al. Among authors: koszycki d. Am J Psychiatry. 1992 Jul;149(7):962-4. doi: 10.1176/ajp.149.7.962. Am J Psychiatry. 1992. PMID: 1609879

4

[Is cholecystokinin a biological support in panic attacks?].

Bourin M, Bradwejn J, Koszycki D. Bourin M, et al. Among authors: koszycki d. Encephale. 1991 Sep-Oct;17(5):475-9. Encephale. 1991. PMID: 1686250 Review. French.

5

Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers.

Koszycki D, Bradwejn J, Bourin M. Koszycki D, et al. Eur Neuropsychopharmacol. 1991 May;1(2):137-41. doi: 10.1016/0924-977x(91)90715-7. Eur Neuropsychopharmacol. 1991. PMID: 1821703

6

Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.

Bradwejn J, Koszycki D. Bradwejn J, et al. Among authors: koszycki d. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(2):237-9. doi: 10.1016/0278-5846(91)90086-g. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1908105

7

Dose ranging study of the effects of cholecystokinin in healthy volunteers.

Bradwejn J, Koszycki D, Bourin M. Bradwejn J, et al. Among authors: koszycki d. J Psychiatry Neurosci. 1991 Jul;16(2):91-5. J Psychiatry Neurosci. 1991. PMID: 1911739 Free PMC article. Clinical Trial.

8

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.

Bradwejn J, Koszycki D, Shriqui C. Bradwejn J, et al. Among authors: koszycki d. Arch Gen Psychiatry. 1991 Jul;48(7):603-10. doi: 10.1001/archpsyc.1991.01810310021005. Arch Gen Psychiatry. 1991. PMID: 2069490 Clinical Trial.

9

Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.

Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Bradwejn J, et al. Among authors: koszycki d. J Clin Psychopharmacol. 1990 Dec;10(6):403-8. doi: 10.1097/00004714-199010060-00004. J Clin Psychopharmacol. 1990. PMID: 2126794 Clinical Trial.

10

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.

Bradwejn J, Koszycki D, Meterissian G. Bradwejn J, et al. Among authors: koszycki d. Can J Psychiatry. 1990 Feb;35(1):83-5. doi: 10.1177/070674379003500115. Can J Psychiatry. 1990. PMID: 2180549 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters